EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 12 (Décembre 2021) Med Sci (Paris), 37 12 (2021) 1119-1124 Références
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 12, Décembre 2021
Vésicules extracellulaires
Page(s) 1119 - 1124
Section Vésicules extracellulaires
DOI https://doi.org/10.1051/medsci/2021204
Publié en ligne 20 décembre 2021
  1. Soehnlein O, Libby P. Targeting inflammation in atherosclerosis — from experimental insights to the clinic. Nat Rev Drug Discov 2021; 20 : 589–610. [CrossRef] [PubMed] [Google Scholar]
  2. van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 2018 ; 19 : 213–228. [CrossRef] [PubMed] [Google Scholar]
  3. Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015 ; 4 : 1–60. [Google Scholar]
  4. Boulanger CM, Loyer X, Rautou P-E, et al. Extracellular vesicles in coronary artery disease. Nat Rev Cardiol 2017 ; 14 : 259–272. [CrossRef] [PubMed] [Google Scholar]
  5. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001 ; 104 : 2649–2652. [CrossRef] [PubMed] [Google Scholar]
  6. Sarlon-Bartoli G, Bennis Y, Lacroix R, et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol 2013 ; 62 : 1436–1441. [CrossRef] [PubMed] [Google Scholar]
  7. Sinning JM, Losch J, Walenta K, et al. Circulating CD31 +/Annexin V + microparticles correlate with cardiovascular outcomes. Eur Heart J 2011 ; 32 : 2034–2041. [CrossRef] [PubMed] [Google Scholar]
  8. Nozaki T, Sugiyama S, Koga H, et al. Significance of a Multiple Biomarkers Strategy Including Endothelial Dysfunction to Improve Risk Stratification for Cardiovascular Events in Patients at High Risk for Coronary Heart Disease. J Am Coll Cardiol 2009 ; 54 : 601–608. [CrossRef] [PubMed] [Google Scholar]
  9. Loyer X, Potteaux S, Vion A, et al. Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and Atherosclerosis in Mice. Circ Res 2014 ; 114 : 434–443. [CrossRef] [PubMed] [Google Scholar]
  10. Zu L, Ren C, Pan B, et al. Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells. Int J Cardiol 2016 ; 202 : 756–759. [CrossRef] [PubMed] [Google Scholar]
  11. Zakharova L, Svetlova M, Fomina AF. T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 2007 ; 212 : 174–181. [CrossRef] [PubMed] [Google Scholar]
  12. Pakala R.. Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation. Cardiovasc Radiat Med 2004 ; 5 : 20–26. [CrossRef] [PubMed] [Google Scholar]
  13. Sarkar A, Mitra S, Mehta S, et al. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS One 2009 ; 4 [Google Scholar]
  14. Leroyer AS, Isobe H, Lesèche G, et al. Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques. J Am Coll Cardiol 2007 ; 49 : 772–777. [CrossRef] [PubMed] [Google Scholar]
  15. Mayr M, Grainger D, Mayr U, et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet 2009 ; 2 : 379–388. [CrossRef] [PubMed] [Google Scholar]
  16. Tripisciano C, Weiss R, Eichhorn T, et al. Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin. Sci Rep 2017 ; 7 : 1–11. [CrossRef] [PubMed] [Google Scholar]
  17. Merten M, Pakala R, Thiagarajan P, et al. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999 ; 99 : 2577–2582. [CrossRef] [PubMed] [Google Scholar]
  18. Srikanthan S, Li W, Silverstein RL, et al. Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. J Thromb Haemost 2014 ; 12 : 1906–1917. [CrossRef] [PubMed] [Google Scholar]
  19. Leroyer AS, Rautou PE, Silvestre JS, et al. CD40 Ligand+ Microparticles From Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and Angiogenesis. A Potential Mechanism for Intraplaque Neovascularization. J Am Coll Cardiol 2008 ; 52 : 1302–1311. [CrossRef] [PubMed] [Google Scholar]
  20. Michel JB, Virmani R, Arbustini E, et al. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011 ; 32 [PubMed] [Google Scholar]
  21. Wadey RM, Connolly KD, Mathew D, et al. Inflammatory adipocyte-derived extracellular vesicles promote leukocyte attachment to vascular endothelial cells. Atherosclerosis 2019 ; 283 : 19–27. [CrossRef] [PubMed] [Google Scholar]
  22. Wang F, Chen F, Shang Y, et al. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE −/− mice. Int J Cardiol 2018 ; 265 : 181–187. [CrossRef] [PubMed] [Google Scholar]
  23. Poisson J, Tanguy M, Davy H, et al. Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm. J Clin Invest 2020; 130 : 2630–43. [Google Scholar]
  24. Camus SM, De Moraes JA, Bonnin P, et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood 2015 ; 125 : 3805–3814. [CrossRef] [PubMed] [Google Scholar]
  25. Sinning JM, Losch J, Walenta K, et al. Circulating CD31 +/Annexin V + microparticles correlate with cardiovascular outcomes. Eur Heart J 2011 ; 32 : 2034–2041. [CrossRef] [PubMed] [Google Scholar]
  26. Deddens JC, Vrijsen KR, Colijn JM, et al. Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury. J Cardiovasc Transl Res. 2016 ; 9 : 291–301. [CrossRef] [PubMed] [Google Scholar]
  27. Rodriguez JA, Orbe J, Saenz-Pipaon G, et al. Selective increase of cardiomyocyte derived extracellular vesicles after experimental myocardial infarction and functional effects on the endothelium. Thromb Res 2018 ; 170 : 1–9. [CrossRef] [PubMed] [Google Scholar]
  28. Anselmo A, Frank D, Papa L, et al. Myocardial hypoxic stress mediates functional cardiac extracellular vesicle release. Eur Heart J 2021; 42 : 2780–92. [CrossRef] [PubMed] [Google Scholar]
  29. Akbar N, Digby JE, Cahill TJ, et al. Endothelium-derived extracellular vesicles promote splenic monocyte mobilization in myocardial infarction. JCI insight 2017; 2. [Google Scholar]
  30. Loyer X, Zlatanova I, Devue C, et al. Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction short communication. Circ Res 2018 ; 123 : 100–106. [CrossRef] [PubMed] [Google Scholar]
  31. Nicolás-Ávila JA, Lechuga-Vieco A V., Esteban-Martínez L, et al. A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart. Cell 2020; 183 : 94–109.e23. [CrossRef] [PubMed] [Google Scholar]
  32. Bahtiyar G, Gutterman D, Lebovitz H. Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus. Curr Diab Rep 2016 ; 16 : 116. [CrossRef] [PubMed] [Google Scholar]
  33. Freeman DW, Noren Hooten N, Eitan E, et al. Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes. Diabetes 2018 ; 67 : 2377–2388. [CrossRef] [PubMed] [Google Scholar]
  34. Gan L, Xie D, Liu J, et al. Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice. Circulation 2020; 141 : 968–83. [CrossRef] [PubMed] [Google Scholar]
  35. Di Carli MF, Janisse J, Ager J, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003 ; 41 : 1387–1393. [CrossRef] [PubMed] [Google Scholar]
  36. Chen J-X, Zeng H, Reese J, et al. Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model. Am J Physiol Circ Physiol 2012 ; 302 : H1003–H1012. [CrossRef] [PubMed] [Google Scholar]
  37. Caporali A, Meloni M, Völlenkle C, et al. Deregulation of microRNA-503 Contributes to Diabetes Mellitus-Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia. Circulation 2011 ; 123 : 282–291. [CrossRef] [PubMed] [Google Scholar]
  38. Caporali A, Meloni M, Nailor A, et al. p75NTR-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia. Nat Commun 2015 ; 6 : 8024. [CrossRef] [PubMed] [Google Scholar]
  39. Njock MS, Cheng HS, Dang LT, et al. Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. Blood 2015 ; 125 : 3202–3212. [CrossRef] [PubMed] [Google Scholar]
  40. Jansen F, Yang X, Hoelscher M, et al. Endothelial microparticle-mediated transfer of microRNA-126 promotes vascular endothelial cell repair via spred1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013 ; 128 : 2026–2038. [CrossRef] [PubMed] [Google Scholar]
  41. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009 ; 2 [Google Scholar]
  42. Wu K, Yang Y, Zhong Y, et al. The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway. Am J Physiol Metab 2016 ; 310 : E828–E837. [Google Scholar]
  43. Nakagami H, Kaneda Y, Ogihara T, et al. Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis. Curr Diabetes Rev 2005 ; 1 : 59–63. [CrossRef] [PubMed] [Google Scholar]
  44. Nandi SS, Mishra PK. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy. Advances in experimental medicine and biology. Adv Exp Med Biol 2018 : 47–59. [CrossRef] [PubMed] [Google Scholar]
  45. Wang X, Huang W, Liu G, et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol 2014 ; 74 : 139–150. [CrossRef] [PubMed] [Google Scholar]
  46. Garcia NA, Ontoria-Oviedo I, González-King H, et al. Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells. PLoS One 2015 ; 10 : e0138849. [CrossRef] [PubMed] [Google Scholar]
  47. Wiklander OPB, Brennan M, Lötvall J, et al. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 2019 ; 11 : 8521. [CrossRef] [Google Scholar]
  48. Hergenreider E, Heydt S, Tréguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012 ; 14 : 249–256. [CrossRef] [PubMed] [Google Scholar]
  49. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: A novel stem cell-based therapy for cardiovascular disease. Regen Med 2011 ; 6 : 481–492. [CrossRef] [PubMed] [Google Scholar]
  50. Pezzana C, Agnely F, Bochot A, et al. Extracellular Vesicles and Biomaterial Design: New Therapies for Cardiac Repair. Trends Mol Med 2021; 27 : 231–47. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.